Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Intelligent Bio Solutions Inc. (INBS) had Revenue of $0.73M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$0.73M
Net Income	$-2.54M
Cost of Goods Sold	$0.39M
Gross Profit	$0.34M
Operating Expenses	$3.28M
Operating Income	$-2.55M
Non-Operating Income/Expense	$0.00M
Pre-Tax Income	$-2.55M
Normalized Pre-Tax Income	$-2.55M
Income after Taxes	$-2.55M
Income from Continuous Operations	$-2.55M
Consolidated Net Income/Loss	$-2.55M
Normalized Income after Taxes	$-2.55M
EBIT	$-2.55M
EBITDA	$-2.32M
Weighted-Average Shares Outstanding (Basic)	5.77M
Weighted-Average Shares Outstanding (Diluted)	5.77M
Earnings per Share (EPS) (Basic)	$-0.44
Earnings per Share (EPS) (Diluted)	$-0.44
Balance Sheet Financials
Current Assets	$5.11M
Property, Plant, and Equipment	$0.55M
Long-Term Assets	$4.48M
Total Assets	$9.58M
Current Liabilities	$4.56M
Long-Term Debt	--
Long-Term Liabilities	$0.08M
Total Liabilities	$4.64M
Common Equity	$4.94M
Tangible Shareholders Equity	$1.14M
Shareholders Equity	$4.94M
Common Shares Outstanding	6.79M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-7.47M
Cash Flow from Investing Activities	$-0.02M
Cash Flow from Financial Activities	$4.00M
Beginning Cash	$6.30M
End Cash	$2.81M
Increase/Decrease in Cash	$-3.50M
Stock-Based Compensation	$0.23M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.12
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	0.53
Gross Margin	46.84%
Operating Margin	-350.30%
EBIT Margin	-350.30%
EBITDA Margin	--
Pre-Tax Profit Margin	-349.95%
Profit Margin	-348.97%
Free Cash Flow	$-7.49M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.08
Inventory Turnover	0.57
Receiveable Turnover	0.71
Days Sales in Receivables	127.34
Return on Equity	-51.59%
Return on Tangible Equity	-223.78%
Return on Assets	-26.61%
Return on Investments	-51.59%
Book Value Per Share	$0.73
Free Cash Flow per Share	$-1.30
Operating Cash Flow per Share	$-1.29

Data from Zacks Investment Research, Inc.